The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has awarded a $26.5K firm fixed-price purchase order to Ionoptix LLC of Westwood, Massachusetts, for the procurement and delivery of a modified Inverted Olympus IX73 fluorescence microscope system. This non-severable award, issued on August 4, 2025, with completion scheduled for September 30, 2025, represents a sole-source acquisition without small business set-aside designation. The microscope is specifically engineered to integrate with Ionoptix's existing Cardiac Slice System and features advanced fluorescence capabilities, motorized components, and live-cell imaging functionality designed to support alcohol-related cardiovascular disease research. The contract encompasses delivery, installation, and onsite training services to ensure proper system integration and operational capability at the research facility.
Ionoptix LLC, a foreign-owned biomedical research equipment manufacturer registered in SAM.gov since 2017, has established a track record of providing specialized research instrumentation to multiple federal agencies, including the National Institutes of Health and Department of Veterans Affairs. The company's federal contract history demonstrates consistent expertise in supplying sophisticated cardiac and cellular research systems on a firm fixed-price basis. This award supports NIAAA's research mission to investigate alcohol's effects on cardiovascular health and represents the agency's continued investment in mission-critical laboratory equipment required for advanced biomedical research operations.